SCOTT ARBAUGH: Open Payments
NPI 1861553513 · O FALLON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$34,951 in 175 payments from 17 companies in 2025. Trend: 2023 $19,008 · 2024 $38,300 · 2025 $34,951
Speaker / faculty: $31,289Food & beverage: $2,848Travel & lodging: $815
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 48 | $23,588 |
| ABBVIE INC. | 47 | $9,881 |
| E.R. Squibb & Sons, L.L.C. | 17 | $363 |
| Axsome Therapeutics, Inc. | 11 | $212 |
| Alkermes, Inc. | 10 | $190 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $165 |
| Collegium Pharmaceutical, Inc. | 8 | $154 |
| Neurocrine BioSciences, Inc. | 4 | $93 |
| Sage Therapeutics, LLC | 4 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
Products named: REXULTI, VRAYLAR, COBENFY, Auvelity, ARISTADA, CAPLYTA, Jornay PM, INGREZZA.
Industry payments across MO — which companies pay providers there.
